Oncolytics Biotech

(NASDAQ) ONCY

Current Price$0.90

Market Cap$90.36M

Since IPO (2001)-98%

5 Year-71%

1 Year+58%

1 Month+7%

Oncolytics Biotech Financials at a Glance

Market Cap

$90.36M

Revenue (TTM)

$0.00

Net Income (TTM)

$28.76M

EPS (TTM)

$-0.23

P/E Ratio

-4.00

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$0.90

Volume

4,552

Open

$0.95

Price

$0.90

Volume

4,552

Open

$0.95

Previous Close

$0.90

Daily Range

$0.89 - $0.95

52-Week Range

$0.33 - $1.51

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$0.90

Volume

4,552

Open

$0.95

Previous Close

$0.90

Daily Range

$0.89 - $0.95

52-Week Range

$0.33 - $1.51

ONCY News

These 3 Stocks Aren't as Wobbly as They Appear

Rich DupreyFeb 21, 2013

This Week in Biotech

Sean WilliamsFeb 9, 2013

3 Humongous Health-Care Stocks This Week

Keith SpeightsFeb 9, 2013

Oncolytics Presents Promising Phase 1 Data in Colorectal Cancer

Brian Orelli, PhDJan 28, 2013

Could a Virus Make You Lots of Money?

Keith SpeightsDec 18, 2012

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oncolytics Biotech

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jared Kelly

Website

www.oncolyticsbiotech.com

Headquarters

Calgary, AB T2R 0C5, CA

ONCY Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-11839%

Return on Capital

-19%

Return on Assets

-4%

Earnings Yield

-25.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$90.36M

Shares Outstanding

100.36M

Volume

4.55K

Avg. Volume

1.35M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$28.73M

EBITDA

$28.73M

Operating Cash Flow

$20.11M

Capital Expenditure

$6.00K

Free Cash Flow

$20.11M

Cash & ST Invst.

$5.20M

Total Debt

$563.00K

Oncolytics Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$90.36M

N/A

Market Cap/Employee

$3.23M

N/A

Employees

N/A

Net Income

$1.51M

+81.2%

EBITDA

$1.65M

+80.2%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$4.64M

-68.8%

Accounts Receivable

$573.00K

+742.6%

Inventory

$0.00

N/A

Long Term Debt

$370.00K

-53.0%

Short Term Debt

$193.00K

-30.3%

Return on Assets

-3.79%

N/A

Return on Invested Capital

-19.40%

N/A

Free Cash Flow

$1.49M

+81.1%

Operating Cash Flow

$1.49M

+81.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

COYACoya Therapeutics, Inc.

COYACoya Therapeutics, Inc.$4.26-3.18%

CLNNClene Inc.

CLNNClene Inc.$5.85-3.47%

TILInstil Bio, Inc.

TILInstil Bio, Inc.$8.08-0.62%

ATOSAtossa Therapeutics, Inc.

ATOSAtossa Therapeutics, Inc.$5.49+0.73%

TVGNTevogen Bio Holdings Inc.

TVGNTevogen Bio Holdings Inc.$6.49-7.29%

MGNXMacroGenics, Inc.

MGNXMacroGenics, Inc.$3.01-1.31%

WHWKWhitehawk Therapeutics Inc

WHWKWhitehawk Therapeutics Inc$4.13-0.72%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$84.52-0.01%

NOKNokia

NOKNokia$11.30+0.05%

POETPoet Technologies

POETPoet Technologies$8.03+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$60.74-0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.14-0.01%

PFEPfizer

PFEPfizer$26.48-0.01%

RIGTransocean

RIGTransocean$6.79+0.04%

Questions About ONCY

What is the current price of Oncolytics Biotech?

Oncolytics Biotech is trading at $0.90 per share.

What is the 52-week range for Oncolytics Biotech?

Over the past 52 weeks, Oncolytics Biotech has traded between $0.33 and $1.51.

How much debt does Oncolytics Biotech have?

As of the most recent reporting period, Oncolytics Biotech reported total debt of $563,000.

How much cash does Oncolytics Biotech have on hand?

Oncolytics Biotech reported $5.20M in cash and cash equivalents in its most recent financial results.

What is Oncolytics Biotech’s dividend yield?

Oncolytics Biotech does not currently have a dividend yield.

Oncolytics Biotech

Oncolytics Biotech Financials at a Glance

ONCY News

This High-Risk, High-Reward Biotech Is Worth a Look

A New Cancer-Killing Virus

Can Financial Innovation Unlock a Cure for Cancer?

These 3 Stocks Aren't as Wobbly as They Appear

This Week in Biotech

3 Humongous Health-Care Stocks This Week

Oncolytics Presents Promising Phase 1 Data in Colorectal Cancer

Could a Virus Make You Lots of Money?

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Oncolytics Biotech

ONCY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Oncolytics Biotech Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ONCY

What is the current price of Oncolytics Biotech?

What is the 52-week range for Oncolytics Biotech?

How much debt does Oncolytics Biotech have?

How much cash does Oncolytics Biotech have on hand?

What is Oncolytics Biotech’s dividend yield?

Premium Investing Services